Berenberg Bank upgraded shares of Spire Healthcare Group (LON:SPI) to a buy rating in a research note published on Wednesday, MarketBeat reports. They currently have GBX 310 ($4.15) price target on the stock, up from their prior price target of GBX 270 ($3.62).

A number of other brokerages have also issued reports on SPI. Liberum Capital reiterated a hold rating and set a GBX 270 ($3.62) price target on shares of Spire Healthcare Group in a research note on Tuesday, October 10th. Numis Securities reiterated an add rating and set a GBX 350 ($4.69) price target on shares of Spire Healthcare Group in a research note on Thursday, September 14th. Jefferies Group dropped their price target on shares of Spire Healthcare Group from GBX 350 ($4.69) to GBX 259 ($3.47) and set a hold rating on the stock in a research note on Monday, September 25th. Finally, J P Morgan Chase & Co dropped their price target on shares of Spire Healthcare Group from GBX 376 ($5.04) to GBX 339 ($4.54) and set a neutral rating on the stock in a research note on Friday, September 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Spire Healthcare Group currently has an average rating of Hold and an average target price of GBX 309.86 ($4.15).

Spire Healthcare Group (LON SPI) traded down GBX 2.44 ($0.03) during midday trading on Wednesday, reaching GBX 244.26 ($3.27). 1,310,000 shares of the company’s stock were exchanged, compared to its average volume of 3,220,000. Spire Healthcare Group has a one year low of GBX 218.20 ($2.92) and a one year high of GBX 362.10 ($4.85).

Spire Healthcare Group (LON:SPI) last issued its quarterly earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.12) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of GBX 8.60 ($0.12) by GBX 0.10 ($0.00). Spire Healthcare Group had a net margin of 1.85% and a return on equity of 1.71%. The business had revenue of £481 million for the quarter.

The business also recently disclosed a dividend, which will be paid on Tuesday, December 12th. Investors of record on Thursday, November 16th will be issued a dividend of GBX 1.30 ($0.02) per share. This represents a yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th.

In related news, insider Peter R. Bamford acquired 5,000 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The shares were purchased at an average price of GBX 240 ($3.21) per share, with a total value of £12,000 ($16,070.71). Also, insider Justin Ash acquired 89,100 shares of the firm’s stock in a transaction that occurred on Friday, September 29th. The shares were bought at an average cost of GBX 224 ($3.00) per share, for a total transaction of £199,584 ($267,288.07). In the last three months, insiders have purchased 178,600 shares of company stock worth $41,184,900.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/02/spire-healthcare-group-spi-lifted-to-buy-at-berenberg-bank.html.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Stock Ratings for Spire Healthcare Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group Plc and related stocks with our FREE daily email newsletter.